Amended Statement of Ownership: Private Transaction (sc 13e3/a)
12 10월 2022 - 6:04AM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13E-3
(Rule 13e-100)
(Amendment No. 2)
Rule 13e-3 Transaction Statement under Section 13(e)
of the Securities Exchange Act of 1934
LAIX Inc.
(Name of the Issuer)
LAIX Inc.
Laix Infinite Co. Ltd.
Prilingo Merger Limited
Yi Wang
Joyx Holdings
Ltd.
Zheren Hu
Muang Holdings Ltd.
Hui
Lin
Ulingo Holdings Ltd.
Tiak Koon Loh
Best
Venture Technology Limited
Tenzing Holdings 2011 Ltd.
Ning Zhang
Sino Avenue
Limited
GGV Capital IV L.P.
GGV Capital IV Entrepreneurs Fund L.P.
GGV Capital Select L.P.
GGV Capital IV L.L.C.
GGV Capital Select L.L.C.
Jixun Foo
Glenn Solomon
Jeffrey Gordon Richards
Hans Tung
Jenny Hong Wei
Lee
(Name of Person(s) Filing Statement)
Class A Ordinary Shares, par value $0.001 per share*
American Depositary Shares, each representing fourteen Class A Ordinary Shares
(Title of Classes of Securities)
50736W204**
(CUSIP
Number of Classes of Securities)
|
|
|
LAIX Inc.
Building C2, No. 1687 Changyang Road
Yangpu District, Shanghai 200090
China Attention: Yi
Wang Telephone: +86-21-3511-7188 |
|
Laix Infinite Co. Ltd.
Prilingo Merger Limited
Yi Wang Joyx Holdings
Ltd. Zheren Hu
Muang Holdings Ltd. Hui
Lin Ulingo Holdings Ltd.
Building C2, No. 1687 Changyang Road
Yangpu District, Shanghai, 200090, China
Telephone: +86-21-3511-7188 |
|
|
Tiak Koon Loh
Best Venture Technology Limited
B21, 9/F, Block B, Repulse Bay Apartment
101 Repulse Bay Road, Hong Kong
Telephone: +852-2144-7656 |
|
Tenzing Holdings 2011 Ltd.
1040 Court St. San
Rafael, CA 94901 United States of America
Telephone:
+1-415-991-5154 |
|
|
Ning Zhang
Sino Avenue Limited 25/F,
Shanghai Tower, No. 501 Middle Yincheng Rd. Pudong New Area, Shanghai, 200120, China
Telephone: +86-21-6210-9966 |
|
GGV Capital IV L.P.
GGV Capital IV Entrepreneurs Fund L.P.
GGV Capital Select L.P.
GGV Capital IV L.L.C. GGV
Capital Select L.L.C. Jixun Foo
Glenn Solomon Jeffrey
Gordon Richards Hans Tung
Jenny Hong Wei Lee
3000 Sand Hill Road, Building 4, Suite 230
Menlo Park, CA 94025
United States of America
Telephone:
+1-650-475-2150 |
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications on Behalf of
the Persons Filing Statement)
With copies to:
|
|
|
|
|
David T. Zhang, Esq.
Rongjing Zhao, Esq.
Kirkland & Ellis
26th Floor, Gloucester Tower
The Landmark 15
Queens Road, Central Hong Kong
Tel: +852-3761-3300 |
|
Peter X. Huang, Esq.
Skadden, Arps, Slate, Meagher &
Flom LLP 30/F, China
World Office 2 No. 1, Jianguomenwai Avenue
Chaoyang District Beijing
100004, China Tel: +86-10-6535-5500 |
|
Haiping Li, Esq.
Skadden, Arps, Slate, Meagher &
Flom LLP JingAn Kerry
Centre, Tower II, 46/F
1539 Nanjing West Road
Shanghai 200040, China
Tel: +86-21-6193-8200 |
This statement is filed in connection with (check the appropriate box):
|
|
|
|
|
a. |
|
☐ |
|
The filing of solicitation materials or an information statement subject to Regulation 14A, Regulation 14C or Rule 13e-3(c) under the Securities Exchange Act of 1934. |
|
|
|
b. |
|
☐ |
|
The filing of a registration statement under the Securities Act of 1933. |
|
|
|
c. |
|
☐ |
|
A tender offer. |
|
|
|
d. |
|
☒ |
|
None of the above. |
Check the following box if the soliciting materials or information statement referred to in checking box (a) are
preliminary copies: ☐
Check the following box if the filing is a final amendment reporting the results of the
transaction: ☒
* |
Not for trading, but only in connection with the quotation of the American depositary shares
(ADSs) on the OTC Pink Limited Information (the OTC Market), each representing fourteen Class A ordinary shares, par value $0.001 per share, of the Company (the Class A Ordinary
Shares). |
** |
CUSIP number of the ADSs, each representing fourteen Class A Ordinary Shares. |
NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THIS TRANSACTION, PASSED UPON THE MERITS
OR FAIRNESS OF THIS TRANSACTION, OR PASSED UPON THE ADEQUACY OR ACCURACY OF THE DISCLOSURE IN THIS TRANSACTION STATEMENT ON SCHEDULE 13E-3. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
INTRODUCTION
This amendment No. 2 (the Final Amendment) to transaction statement pursuant to Rule 13e-3
amends and supplements the transaction statement pursuant to Rule 13e-3 filed with the Securities and Exchange Commission (the SEC) pursuant to Section 13(e) of the Securities Exchange
Act of 1934, as amended (the Exchange Act), on July 11, 2022 and amended on August 8, 2022 (together with the exhibits thereto, as amended, the Transaction Statement). Except as provided herein, this
Final Amendment does not modify any of the information previously reported on the Transaction Statement.
This Final Amendment is being filed jointly by
the following Persons (each, separately, a Filing Person, and collectively, the Filing Persons): (a) LAIX Inc., an exempted company with limited liability incorporated under the laws of the Cayman Islands (the
Company), the issuer of the Ordinary Shares (as defined below), including the Class A Ordinary Shares represented by ADSs, that is subject to the transaction pursuant to Rule 13e-3
under the Exchange Act; (b) Laix Infinite Co. Ltd., an exempted company incorporated with limited liability under the laws of the Cayman Islands (Parent); (c) Prilingo Merger Limited, an exempted company incorporated with
limited liability under the laws of the Cayman Islands and a wholly-owned subsidiary of Parent (Merger Sub); (d) Dr. Yi Wang, co-founder, chairman of the board of the directors, and
chief executive officer of the Company, and Joyx Holdings Ltd., a company incorporated under the laws of the British Virgin Islands beneficially owned by Dr. Yi Wang; (e) Mr. Zheren Hu,
co-founder, director, and chief technology officer of the Company, and Muang Holdings Ltd., a company incorporated under the laws of the British Virgin Islands beneficially owned by Mr. Zheren Hu;
(f) Dr. Hui Lin, co-founder, director, and chief scientist of the Company, and Ulingo Holdings Ltd., a company incorporated under the laws of the British Virgin Islands beneficially owned by
Dr. Hui Lin; (g) Mr. Tiak Koon Loh, independent director of the Company, and Best Venture Technology Limited, a company incorporated under the laws of the British Virgin Islands and a wholly-owned subsidiary of Mr. Tiak Koon Loh;
(h) Tenzing Holdings 2011 Ltd., a company incorporated under the laws of the British Virgin Islands; (i) Ms. Ning Zhang and Sino Avenue Limited, a company incorporated under the laws of the British Virgin Islands and a wholly-owned
subsidiary of Ms. Ning Zhang; and (j) GGV Capital IV L.P., a limited partnership organized under the laws of the State of Delaware, GGV Capital IV Entrepreneurs Fund L.P., a limited partnership organized under the laws of the State of
Delaware, GGV Capital Select L.P., a limited partnership organized under the laws of the State of Delaware, GGV Capital IV L.L.C., a limited liability company organized under the laws of the State of Delaware, GGV Capital Select L.L.C., a limited
liability company organized under the laws of the State of Delaware, Messrs. Jixun Foo, Glenn Solomon, Jeffrey Gordon Richards, Hans Tung and Ms. Jenny Hong Wei Lee.
The Transaction Statement relates to the Agreement and Plan of Merger dated June 17, 2022 (the Merger Agreement) by and among the
Company, Parent and Merger Sub providing for the merger of Merger Sub with and into the Company (the Merger) in accordance with the Part XVI and in particular section 233(7) of the Companies Act, Cap. 22 (Law 3 of 1961, as
consolidated and revised) of the Cayman Islands (the Cayman Islands Companies Act), with the Company continuing as the surviving company (as defined in the Cayman Islands Companies Act) resulting from the Merger.
This Final Amendment is being filed pursuant to Rule 13e-3(d)(3) to report the results of the transactions that are
the subject of the Transaction Statement.
All information contained in the Transaction Statement concerning each Filing Person has been supplied by such
Filing Person.
ITEM 15 |
ADDITIONAL INFORMATION |
Item 15 is hereby amended and supplemented as follows:
(c) |
Other Material Information |
On October 11, 2022, the Company and Merger Sub filed with the Registrar of Companies of the Cayman Islands a plan of merger (the Plan of
Merger), pursuant to which the Merger became effective on October 11, 2022 (the Effective Time), with Merger Sub merging with and into the Company and the Company becoming a private company wholly owned by Parent.
Under the terms of the Merger Agreement, at the Effective Time, (i) each ordinary share of the Company
(each an Ordinary Share) issued and outstanding immediately prior to the Effective Time (other than the Excluded Shares (as defined in the Merger Agreement), the Dissenting Shares (as defined in the Merger Agreement) and any
Class A Ordinary Shares represented by ADSs) was cancelled and ceased to exist in exchange for the right to receive US$0.1357 in cash per Ordinary Share without interest, and (ii) each ADS (other than ADSs representing the Excluded Shares)
issued and outstanding immediately prior to the Effective Time, together with the underlying Class A Ordinary Shares represented by such ADSs, was cancelled and ceased to exist in exchange for the right to receive US$1.90 in cash per ADS
without interest, less an ADS cancellation fee of US$0.05 per ADS and any applicable expenses, taxes and other governmental charges.
In connection with
the consummation of the Merger, the ADS program of the Company will terminate and the ADSs will no longer be quoted on the OTC Pink Market, effective as of market close on October 11, 2022. The Company intends to file with the SEC a Form 15
suspending the Companys reporting obligations under the Exchange Act. The Companys obligations to file with or furnish to the SEC certain reports and forms, including Form 20-F and Form 6-K, will be suspended immediately as of the filing date of the Form 15 and will terminate once the deregistration becomes effective.
SIGNATURE
After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Transaction Statement is true, complete and
correct.
Dated: October 11, 2022
|
|
|
|
|
LAIX Inc. |
|
|
By: |
|
/s/ Li-Lan Cheng |
|
|
Name: |
|
Li-Lan Cheng |
|
|
Title: |
|
Director and Member of the Special Committee |
|
Laix Infinite Co. Ltd. |
|
|
By: |
|
/s/ Yi Wang |
|
|
Name: |
|
Yi Wang |
|
|
Title: |
|
Director |
|
Prilingo Merger Limited |
|
|
By: |
|
/s/ Yi Wang |
|
|
Name: |
|
Yi Wang |
|
|
Title: |
|
Director |
|
Yi Wang |
|
|
By: |
|
/s/ Yi Wang |
|
|
Name: |
|
Yi Wang |
|
Joyx Holdings Ltd. |
|
|
By: |
|
/s/ Yi Wang |
|
|
Name: |
|
Yi Wang |
|
|
Title: |
|
Director |
|
Zheren Hu |
|
|
By: |
|
/s/ Zheren Hu |
|
|
Name: |
|
Zheren Hu |
|
Muang Holdings Ltd. |
|
|
By: |
|
/s/ Zheren Hu |
|
|
Name: |
|
Zheren Hu |
|
|
Title: |
|
Director |
|
Hui Lin |
|
|
By: |
|
/s/ Hui Lin |
|
|
Name: |
|
Hui Lin |
|
|
|
|
|
Ulingo Holdings Ltd. |
|
|
By: |
|
/s/ Hui Lin |
|
|
Name: |
|
Hui Lin |
|
|
Title: |
|
Director |
|
Tiak Koon Loh |
|
|
By: |
|
/s/ Tiak Koon Loh |
|
|
Name: |
|
Tiak Koon Loh |
|
Best Venture Technology Limited |
|
|
By: |
|
/s/ Tiak Koon Loh |
|
|
Name: |
|
Tiak Koon Loh |
|
|
Title: |
|
Director |
|
Tenzing Holdings 2011 Ltd. |
|
|
By: |
|
/s/ Yibo Shao |
|
|
Name: |
|
Yibo Shao |
|
|
Title: |
|
Director |
|
Ning Zhang |
|
|
By: |
|
/s/ Ning Zhang |
|
|
Name: |
|
Ning Zhang |
|
Sino Avenue Limited |
|
|
By: |
|
/s/ Ning Zhang |
|
|
Name: |
|
Ning Zhang |
|
|
Title: |
|
Director |
|
GGV Capital IV L.P. |
By: GGV Capital IV L.L.C., its General Partner |
|
|
By: |
|
/s/ Terence Jen |
|
|
Name: |
|
Terence Jen |
|
|
Title: |
|
Attorney-in-Fact |
|
GGV Capital IV Entrepreneurs Fund L.P. |
By: GGV Capital IV L.L.C., its General Partner |
|
|
By: |
|
/s/ Terence Jen |
|
|
Name: |
|
Terence Jen |
|
|
Title: |
|
Attorney-in-Fact |
|
|
|
|
|
GGV Capital Select L.P. By: GGV
Capital Select L.L.C., its General Partner |
|
|
By: |
|
/s/ Terence Jen |
|
|
Name: |
|
Terence Jen |
|
|
Title: |
|
Attorney-in-Fact |
|
GGV Capital IV L.L.C. |
|
|
By: |
|
/s/ Terence Jen |
|
|
Name: |
|
Terence Jen |
|
|
Title: |
|
Attorney-in-Fact |
|
GGV Capital Select L.L.C. |
|
|
By: |
|
/s/ Terence Jen |
|
|
Name: |
|
Terence Jen |
|
|
Title: |
|
Attorney-in-Fact |
|
Jixun Foo |
|
|
By: |
|
/s/ Jixun Foo |
|
|
Name: |
|
Jixun Foo |
|
Glenn Solomon |
|
|
By: |
|
/s/ Glenn Solomon |
|
|
Name: |
|
Glenn Solomon |
|
Jeffrey Gordon Richards |
|
|
By: |
|
/s/ Jeffrey Gordon Richards |
|
|
Name: |
|
Jeffrey Gordon Richards |
|
Jenny Hong Wei Lee |
|
|
By: |
|
/s/ Jenny Hong Wei Lee |
|
|
Name: |
|
Jenny Hong Wei Lee |
|
Hans Tung |
|
|
By: |
|
/s/ Hans Tung |
|
|
Name: |
|
Hans Tung |
LAIX (NYSE:LAIX)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025
LAIX (NYSE:LAIX)
과거 데이터 주식 차트
부터 1월(1) 2024 으로 1월(1) 2025